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 High Risk Diagnosis   
Severity of Reaction Symptoms Treatment
Mild Reactions
For example flushing that is not 
bothersome to the patient
Antihistamines are usually not necessary, 
restart the infusion at one-half the previous rate.
Moderate Reactions
For example the patient is uncomfortable 
due to flushing or pruritus.Hemodynami-
cally stable, not experiencing chest pain 
or muscle spasm
Treatment with an antihistamine such as  clemas-
tine or diphenhydramine (Grade 2C) is suggested.
Severe Reactions
For example muscle spasms, chest pain, 
hypotension etc
In addition to stopping the infusion, administration 
of H1 antihistamine intravenously (clemastine etc) 
and H2 antihistamine intravenously (ranitidine) is 
recommended. (Grade 2C) IV fluids for hypoten-
sion may be needed. Infuse any subsequent dose of 
Vancomycin over four hours.
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Leflunomide Increased risk of severe liver injury in patients using this drug
Tramadol Risk of suicide for patients who are addiction-prone, taking tranquilisers or antidepressant drugs
PPIs’ Increased risk of fractures of hip, wrist and spine bones
GnRH Agonists Increased risk of diabetes and cardiovascular events in patients receiving GnRH agonists
Propylthiouracil
Reports of severe liver injury and acute liver failure. Patients should be closely monitored for signs and 
symptoms of liver injury during the six months of therapy initiation
Simvastatin Increased risk of muscle injury (myopathy) with high doses
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High Risk Diagnosis 
Recording High Risk Diagnosis in NPHA
PharmacistPhysician
No
Yes
No
Yes
No
No
Yes
Drug contraindicate 
with HRD entered for 
patient
Proceed with 
normal order 
entry
HRD saved for 
selected visit?
End
Selects Inpatient 
or ER patient for 
order entry
Selects HRD  for  
patient
HRD updated 
for current 
visit?
Start
Modify selected 
drug?
System would 
display 
warning 
message 
System would 
prompt 
physician to 
update HRD for 
selected patient 
Yes
No
Yes
Proceed with 
normal order 
entry
Modify selected 
drug?
End
Prescribed drug 
contraindicates with 
high risk diagnosis 
entered for patient
System would 
display 
warning 
message 
Selects physician 
order for 
processing/enters 
manual order for 
patient
Start
No
Known 
HRD?
Yes
No Mark visit as HRD 
Not Known
• HRD would be maintained on patient 
MR number. 
• System would display diagnosis info, if 
previously recorded for patient 
• This info would also be displayed on 
patient profile and other reports
• HRD information  can also be updated 
later from order entry form. System 
would display relevant lab results for 
current visit
Drug is used for 
treatment of any HRD 
and specific HRD is 
not updated for 
patient
System 
would notify 
regarding  
missing HRD 
info 
Yes
Enters order 
for selected 
patient
Yes
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